Review: An overview and analysis of novel oral anticoagulants and their dental implications
Sign Up to like & getrecommendations! Published in 2018 at "Gerodontology"
DOI: 10.1111/ger.12327
Abstract: BACKGROUND Dabigatran, rivaroxaban, apixaban and edoxaban are approved novel oral anticoagulants (NOACs) as alternatives to Vitamin K antagonists (VKA). Physicians are prescribing an ever-increasing amount these drugs to their patients due to various advantages over… read more here.
Keywords: review overview; overview analysis; oral anticoagulants; novel oral ... See more keywords